Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Minerva Neurosciences, a clinical-stage biopharmaceutical company focused on CNS disorders, announced that its management will participate in two upcoming investor conferences in New York, including the Wells Fargo Healthcare Conference and the 2026 Cantor Global Healthcare Conference. The company will webcast its presentations and provide replay a…
Rezolve Ai, a US-listed AI-powered commerce technology company, has formed a global strategic alliance with Tech Mahindra, a leading Indian technology consulting firm, to accelerate large-scale deployment of agentic commerce. The partnership leverages Rezolve Ai's Brain Suite AI platform and Tech Mahindra's global consulting and integration capabil…
Nano Labs Ltd, a Nasdaq-listed Web 3.0 infrastructure and crypto treasury company, announced its unaudited financial results for H1 2026, reporting a net loss of RMB316.7 million (US$46.5 million), a sharp decline compared to the same period in 2025. The company attributed losses primarily to decreased cryptocurrency valuations, especially BNB, and…
Meta once again delivered results that reinforce its ad dominance and AI monetization runway. With a $1.45T market cap, 21x earnings and $41B in free cash flow, the setup favors accumulation on pullbacks. We lay out an actionable trade: entry $565.00, stop $525.00, target $700.00 over a 180 trading day horizon.
Core AI Holdings reported strong Q2 2026 financial results with 56% year-over-year revenue growth to $22.4 million and a 97% reduction in gross loss, bringing its gross margin close to breakeven. The improvement was driven by optimized advertising and user acquisition strategies, particularly in its AI-enabled mobile gaming segment. The company als…
Callaway (ELY) combines a strong brand, recurring consumables revenue and improving direct-to-consumer channels. Recent weakness has pushed the stock to a valuation that understates cyclical recovery potential. This trade targets a rebound driven by product cadence, margin expansion and modest multiple re-rating.
AXA looks positioned to outperform over the next 45 trading days as underwriting profits normalize, investment income benefits from higher rates, and the balance sheet remains capital-robust enough to support buybacks and dividends. This trade idea outlines a mid-term long entry with concrete risk controls and clear catalysts to watch.
Mizuho reaffirmed Welltower Inc. as its leading REIT selection and retained an Outperform rating on Ventas Inc., citing strong adjusted funds from operations (AFFO) growth forecasts and encouraging second-quarter revenue results. The firm set price targets implying roughly 8% upside for Welltower and 11% for Ventas, while highlighting valuation dif…
European natural gas benchmarks retreated from session highs on Friday after a multi-session rally, yet remained on course to record a third straight weekly gain. Traders pared some of the geopolitical risk premium after reports that regional mediators had opened talks to protect commercial transit through the Strait of Hormuz, but physical market …
Mobia Medical announces that implantable paired Vagus Nerve Stimulation (VNS) has been recognized in the 2026 American Heart Association (AHA) stroke rehabilitation guidelines as a treatment option to improve upper-limb function in chronic stroke survivors. Their FDA-approved Vivistim® Paired VNS System is the only device delivering this therapy. T…
Hecate Energy and EGH Acquisition Corp. announced the resolution of lender and litigation matters, enabling progress toward Hecate's planned Nasdaq listing under ticker 'HCTE' via a business combination with EGH. The transaction, valuing Hecate at $1.2 billion pre-money, is expected to close in Q1 2027, providing capital to develop and monetize Hec…
Alnylam Pharmaceuticals stock fell about 6% after AstraZeneca announced that a Phase 3 trial of its experimental silencer therapy for ATTR-CM failed. The study found no benefit for patients who were already taking a stabilizer drug, and most participants were on such therapy at enrollment. The outcome casts uncertainty over the silencer drug approa…
Elastic reported accelerating revenue and cloud adoption that undercuts the narrative of a broad SaaS slowdown. Q1 FY2026 results showed revenue of $478.11M (+15.1% YoY) with Elastic Cloud up 20.1%. Valuation sits at a midteens earnings multiple and EV/Sales near 4.9, leaving room for upside if cloud traction and margins continue to improve. This i…
Marvell Technology reported upbeat revenue forecasts for fiscal 2027 and 2028 but saw its shares fall sharply in premarket trading after investors expressed concerns about when the company will realize the potential upside from a large custom-chip agreement with Alphabet’s Google. Management said some Google-related revenue is already included in n…
Chagee Holdings Limited announced its Q2 2026 unaudited financial results, showing a 2.5% increase in net revenues to RMB3.41 billion and a substantial 387.6% rise in operating income to RMB524.7 million. Despite revenue growth, same store GMV declined 16.1% in Greater China due to economic headwinds and intense competition. The company's teahouse …
iBio, Inc. (NASDAQ: IBIO), a clinical-stage biotech company, announced its FY 2026 financial results and highlighted significant advancements including the initiation of Phase 1 clinical trials for IBIO-600 and IND-enabling studies for IBIO-610 and IBIO-800. The company strengthened its leadership, secured substantial financing extending its cash r…
XORTX Therapeutics Inc. has terminated its investor relations agreement with IR Agency LLC and returned the previously paid marketing fees, opting to postpone its investor relations program while completing its voluntary delisting from the TSX Venture Exchange. The company aims to reduce regulatory complexity and focus on advancing its pharmaceutic…
MoneyHero Limited, a Nasdaq-listed fintech company specializing in AI-powered personal finance aggregation and digital insurance brokerage in Greater Southeast Asia, announced it will release its Q2 2026 results on September 11, 2026, before market open and host a conference call. The firm operates across Singapore, Hong Kong, Taiwan, and the Phili…
Needham's latest Semicap Tracker, its 33rd edition, incorporates July equipment import data for Korea, Taiwan and China, updated global semiconductor sales through June, and memory spot prices through August 21. The report highlights an accelerating sales cycle led by memory, stronger wafer fabrication equipment flows into China, Taiwan and Korea, …
Futures for the S&P 500 and Nasdaq eased on Friday following a technology-led advance driven by Nvidia’s upbeat outlook the day before. Markets were focused on Federal Reserve Chair Kevin Warsh’s first speech at the central bank’s annual Jackson Hole symposium, seeking any guidance on how policy-makers might respond to mixed inflation readings and …
A small but growing cohort of small businesses is experimenting with prediction market platforms to protect against narrowly defined financial risks tied to promotions, labor rules and commodity-linked costs. Trading firms, a market operator and a specialty finance startup have collaborated to craft event contracts that pay out when specified outco…
Didi Global says it will invest more than $200 million in Argentina this year to expand into smaller towns, introduce new transport options such as motorcycle rides and last-mile services, and develop safety-related mapping and AI capabilities. The company anticipates a 25% rise in drivers this year to exceed 500,000, follows a $160 million 2025 in…
Teva Pharmaceutical Industries Ltd. has announced a proposed acquisition of the novel dexmedetomidine sublingual film product, BXCL501, from BioXcel Therapeutics through a court-supervised sale process. The product is under FDA review for at-home treatment of agitation in adults with schizophrenia or bipolar disorder, potentially becoming the first…
Seven people charged over damage to U.S. President Donald Trump’s Turnberry golf resort in Scotland last year have been told prosecutors will seek tougher sentences because the alleged offences are ‘aggravated by reason of having a terrorist connection’. The charges relate to spray-painting of pro-Palestinian slogans, digging up greens and alleged …
A disagreement over whether certain cheese names are generic or reserved for European regional products has emerged as a complication in bilateral trade talks between the United States and Mexico. The row stems from a Mexico-EU deal that grants legal protections to dozens of European cheeses and may affect U.S. exporters who have long used generic …
